ArticleInternal medicine (Tokyo, Japan)2024

Unresectable Combined Hepatocellular-cholangiocarcinoma Treated with Combination Therapy Consisting of Durvalumab Plus Tremelimumab.

Shinji Unome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.